Key result
Off-pump CABG shows no survival benefit over on-pump CABG in adults with HFrEF.
Why the study?
Does off-pump CABG reduce all-cause mortality and postoperative complications compared to on-pump CABG in adults with HFrEF?
Cohort (n=603)
Yes
Does off-pump CABG reduce all-cause mortality and postoperative complications compared to on-pump CABG in adults with HFrEF?
Answers are grounded in this paper and cite their sources.
In patients with HFrEF undergoing CABG, the choice between off-pump and on-pump surgical approaches does not significantly impact short- or mid-term mortality or major postoperative complications.
OBJECTIVE: The optimal surgical strategy for coronary artery bypass grafting (CABG) in patients with heart failure with reduced ejection fraction (HFrEF) is uncertain. This study aimed to compare postoperative outcomes between off-pump/on-pump CABG (OPCAB vs ONCAB) in patients with HFrEF. METHODS: This retrospective cohort study included adults with HFrEF undergoing CABG from the National Health Insurance Research Database, 2001-2021. Primary outcome was all-cause mortality. Secondary outcomes were postoperative complications. Logistic regression was used to determine associations by estimating odds ratios (ORs) with 95% confidence intervals (CIs). After multivariable adjustment, OPCAB was not significantly associated with all-cause mortality within 30 days compared with ONCAB. OPCAB was also not significantly associated with 31-day to one-year all-cause mortality, overall cardiovascular events, IS/TIA, AKI, infection other than pneumonia, sepsis, or pneumonia compared with ONCAB. In stratified analyses, OPCAB was associated with higher odds of sepsis among patients with less extent of coronary artery disease (<3-vessel disease) (aOR = 3.16, 95% CI: 1.24-8.07) and among those with cerebrovascular disease (aOR = 3.40, 95% CI: 1.13-10.21). CONCLUSIONS: In patients with HFrEF undergoing CABG, surgical approach (OPCAB vs ONCAB) was not independently associated with 30-day mortality, 1-year mortality, or major postoperative complications after adjustment. Further prospective studies with detailed operative and patient-level data are still warranted.
No takes yet. Share an insight, caveat, or question.
Tan et al. (2026) conducted a cohort in Heart failure with reduced ejection fraction (HFrEF) (n=603). Off-pump CABG (OPCAB) vs. On-pump CABG (ONCAB) was evaluated on All-cause mortality. Off-pump CABG was not significantly associated with 30-day or 1-year all-cause mortality compared with on-pump CABG in adults with HFrEF.
Synapse has enriched 10 related papers. Consider them for comparative context: